Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)

Clinical trial NCT06710132 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06710132
Sponsor: EMD Serono Research & Development Institute, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumors Gastric Cancer Non-Small Cell Lung Cancer (NSCLC)Pancreatic Cancer Pancreatic Ductal Adenocarcinoma (PDAC)

Start date: 2025-01-29
Primary completion: 2027-12-23
Enrollment: 184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.